Home › Trial NCT03932786
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
- Trial IDNCT03932786
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorVanderbilt-Ingram Cancer Center
- Enrollment900
- Start date2019-01-24
- ConditionsRetinoblastoma · Cancer Survivor · Biological Sibling · Intraocular Retinoblastoma · Unilateral Retinoblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.